Literature DB >> 5381975

[Chromosome findings in gamma D plasmacytoma].

H Siebner, F W Aly, H J Braun.   

Abstract

Mesh:

Substances:

Year:  1969        PMID: 5381975     DOI: 10.1007/bf01879923

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


× No keyword cloud information.
  10 in total

1.  Aberrations induced in human leukocyte chromosomes by 3H-labeled nucleosides.

Authors:  M A BENDER; P C GOOCH; D M PRESCOTT
Journal:  Cytogenetics       Date:  1962

2.  Multiple myeloma without a paraprotein. Report of a case with observations on chromosomal composition.

Authors:  C A Coltman
Journal:  Arch Intern Med       Date:  1967-12

3.  [Diagnosis of the gamma D-plasmacytoma].

Authors:  H J Braun; F W Aly
Journal:  Dtsch Med Wochenschr       Date:  1969-01-17       Impact factor: 0.628

4.  [Chromosome studies in malignant diseases of the lymphoplasmoreticular system with special reference to paraproteinemias].

Authors:  H Siebner
Journal:  Arztl Forsch       Date:  1967-10

5.  [Chromosome studies in paraproteinemia].

Authors:  U Kanzow; B Lange; G Niederalt; A Gropp
Journal:  Klin Wochenschr       Date:  1967-11-01

6.  [Myleran therapy in pregnancy. A case contribution with chromosome examination].

Authors:  N Uhl; P Eberle; E Quellhorst; R Schmidt; W Hunstein
Journal:  Dtsch Med Wochenschr       Date:  1968-09-27       Impact factor: 0.628

7.  Chromosomal abnormalities in multiple myeloma.

Authors:  K C Das; B K Aikat
Journal:  Blood       Date:  1967-12       Impact factor: 22.113

8.  Plasma cell myeloma with D-myeloma protein (IgD myeloma).

Authors:  J L Fahey; P P Carbone; D S Rowe; R Bachmann
Journal:  Am J Med       Date:  1968-09       Impact factor: 4.965

9.  A NEW CLASS OF HUMAN IMMUNOGLOBULINS. I. A UNIQUE MYELOMA PROTEIN.

Authors:  D S ROWE; J L FAHEY
Journal:  J Exp Med       Date:  1965-01-01       Impact factor: 14.307

10.  A NEW CLASS OF HUMAN IMMUNOGLOBULINS. II. NORMAL SERUM IGD.

Authors:  D S ROWE; J L FAHEY
Journal:  J Exp Med       Date:  1965-01-01       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.